News

McKesson Corporation MCK reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $9.86, which beat the Zacks Consensus Estimate of $8.92 by 10.5%. The bottom line improved 39.5% on

Shares of Robinhood Markets Inc. HOOD declined 2.4% in yesterday’s after-market trading session despite solid quarterly results. Its third-quarter 2025 earnings per share of 61 cents handily

Quantum Computing Inc. QUBT or “QCi” is transitioning itself from pure research and development toward scaled-product commercialization, marking a pivotal step in its evolution.

QCi’s product

Xeris Biopharma (XERS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.01. This compares to a loss of $0.06 per share a year ago. These figures are

TripAdvisor (TRIP) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.5 per share a year ago. These figures

Entrada Therapeutics, Inc. (TRDA) came out with a quarterly loss of $1.06 per share versus the Zacks Consensus Estimate of a loss of $1.04. This compares to a loss of $0.35 per share a year ago

Stagwell (STGW) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.22 per share a year ago. These figures

Shift4 Payments (FOUR) came out with quarterly earnings of $1.47 per share, beating the Zacks Consensus Estimate of $1.46 per share. This compares to earnings of $1.04 per share a year ago. These

Monte Rosa Therapeutics (GLUE) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.29 per share a year ago. These

Skillz Inc. (SKLZ) came out with a quarterly loss of $1.14 per share versus the Zacks Consensus Estimate of a loss of $1.28. This compares to a loss of $1.2 per share a year ago. These figures are

Americold Realty Trust Inc. (COLD) came out with quarterly funds from operations (FFO) of $0.35 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.35 per share a year

CyberArk (CYBR) came out with quarterly earnings of $1.2 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.94 per share a year ago. These figures

BlackSky Technology Inc. (BKSY) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to a loss of $0.66 per share a year ago. These

Altice USA, Inc. (ATUS) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.09 per share a year ago. These figures

Angel Oak Mortgage (AOMR) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to a loss of $0.14 per share a year ago. These

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors

The U.S. Department of Energy (“DOE”) recently forged a landmark public-private partnership with tech giants Nvidia (NVDA) and Oracle (ORCL) to build the nation's largest artificial intelligence

Share price of Embraer S.A. EMBJ rose 4.1% to $64.58 on Nov. 5, following its third-quarter 2025 results.The company reported a third-quarter 2025 adjusted earnings of 30 cents per American

STERIS plc STE reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.47, up 15.4% from the year-ago quarter’s figure. The figure surpassed the Zacks Consensus Estimate by 3.8%.

SolarEdge Technologies, Inc. SEDG reported a third-quarter 2025 adjusted loss of 31 cents per share, narrower than the Zacks Consensus Estimate of a loss of 38 cents. The bottom line also improved

Duke Energy DUK is scheduled to release third-quarter 2025 results on Nov. 7, before market open. The company delivered an earnings surprise of 5% in the last reported quarter. Let’s discuss the

ADMA Biologics ADMA reported third-quarter 2025 adjusted earnings per share (EPS) of 16 cents, which were in line with the Zacks Consensus Estimate. In the year-ago quarter, the company reported

Regenxbio (RGNX) came out with a quarterly loss of $1.2 per share versus the Zacks Consensus Estimate of a loss of $1.38. This compares to a loss of $1.17 per share a year ago. These figures are

C4 Therapeutics, Inc. (CCCC) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to a loss of $0.35 per share a year ago. These